Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
2023 · Nature Medicine · 348 citations
https://doi.org/10.1038/s41591-022-02103-8
J
Jixiang Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
985
Citations
17
h-index
20
i10-index
Jixiang Zhang is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Pain Mechanisms and Treatments & Neuroscience and Neuropharmacology Research & Ion channel regulation and function. The author has an h-index of 17, co-authored 44 publications.
ORCID: 0000-0002-1641-8650Papers by this author
worksRE1-silencing transcription factor controls the acute-to-chronic neuropathic pain transition and Chrm2 receptor gene expression in primary sensory neurons
2018 · Journal of Biological Chemistry · 46 citations
https://doi.org/10.1074/jbc.ra118.005846
Histone methyltransferase G9a diminishes expression of cannabinoid CB1 receptors in primary sensory neurons in neuropathic pain
2020 · Journal of Biological Chemistry · 32 citations
https://doi.org/10.1074/jbc.ra119.011053
Development of a replicative plasmid for gene expression in Mycoplasma bovis
2014 · Journal of Microbiological Methods · 8 citations
https://doi.org/10.1016/j.mimet.2014.11.005
Subgroup analysis of the association between the STAT3 rs744166 polymorphisms and the risk of CD.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0109625.t003
Subgroup analysis of the association between STAT3 rs744166 polymorphism and UC by age of onset for GA+AA vs. GG.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0109625.g005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat